Potential Risk Factors | Non-initiators/category total (%) | Unadjusted risk ratio (95% CI) | Adjusted risk ratio (95% CI) n = 568 patientsa |
---|---|---|---|
Age, years (per 5-year increase) | - | 1.03 (1.00-1.05) | 1.06 (1.03-1.08)* |
Sex | |||
Male | 213/789 (27.0%) | Reference | Reference |
Female | 355/982 (36.2%) | 1.34 (1.16-1.54)* | 1.28 (1.11-1.47)* |
Reason for referral | |||
Rule out active TB | 180/446 (40.4%) | Reference | Reference |
Employment screen | 162/430 (37.7%) | 0.93 (0.79-1.10) | 0.90 (0.76-1.06) |
Health science school screen | 42/125 (33.6%) | 0.83 (0.63-1.09) | 0.84 (0.64-1.11) |
Contact | 106/383 (27.7%) | 0.68 (0.56-0.85)* | 0.71 (0.59-0.86)* |
Immunosuppressive therapy | 36/263 (13.7%) | 0.34 (0.24-0.47)* | 0.30 (0.22-0.41)* |
Immigration surveillance | 42/124 (33.9%) | 0.84 (0.64-1.10) | 0.88 (0.68-1.15) |
Year of consultation | |||
2010 | 68/259 (26.3%) | 0.64 (0.49-0.83)* | 0.66 (0.52-0.85)* |
2011 | 70/269 (26.0%) | 0.64 (0.49-0.82)* | 0.65 (0.51-0.84)* |
2012 | 76/235 (32.3%) | 0.79 (0.62-1.01) | 0.80 (0.63-1.01) |
2013 | 80/252 (31.7%) | 0.78 (0.61-0.99)* | 0.78 (0.62-0.98)* |
2014 | 101/289 (34.9%) | 0.85 (0.68-1.07) | 0.86 (0.69-1.05) |
2015 | 81/242 (33.5%) | 0.82 (0.65-1.04) | 0.88 (0.71-1.11) |
2016 | 92/225 (40.9%) | Reference | Reference |